Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol OSTX
- Company OS Therapies Incorporated
- Price $0.79
- Changes Percentage -3.33
- Change -0.0273
- Day Low $0.79
- Day High $0.86
- Year High $2.25
- Year Low $1.15
- Market Cap $75,593,246
- Price Avg 50 EMA (D) $1.63
- Price Avg 200 EMA (D) $1.59
- Exchange AMEX
- Volume 344,819
- Average Volume 642,965
- Open $0.81
- Previous Close $0.82
- EPS -1.02
- PE -1.63
- Earnings Announcement 2026-11-13 12:00:00
- Shares Outstanding $45,538,100
Company brief: OS THERAPIES INCORPORATED (OSTX )
- Healthcare
- Biotechnology
- Mr. Paul A. Romness M.P.H.
- https://ostherapies.com
- US
- N/A
- 08-01-2024
- US68764Y2072
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
